Small Business Informatics Tools for the Pangenome (R43 Clinical Trial Not Allowed)
ID: 357629Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $400K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357629

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-308.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Business Informatics Tools for the Pangenome (R43 Clinical Trial Not Allowed)" aimed at supporting the development of innovative informatics tools that enhance the use of the human pangenome reference. This initiative invites applications from eligible small business concerns (SBCs) to demonstrate the feasibility and commercial potential of such tools, particularly in the fields of clinical, population, and functional genomics. The funding, which can reach up to $400,000, is intended to foster the creation of tools that address significant gaps in genomic research and promote collaboration within the genomics community. Interested applicants must submit their proposals by March 3, 2025, and can find additional information and application guidelines at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-308-Full-Announcement.html
    PAR-25-308.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the National Human Genome Research Institute (NHGRI), has released a Notice of Funding Opportunity (NOFO) aimed at fostering the development of small business informatics tools for the human pangenome. This initiative, under the Small Business Innovation Research (SBIR) grant program (R43), seeks applications from small business concerns (SBCs) that demonstrate the feasibility and commercial potential of such tools, particularly in clinical, population, and functional genomics. The goal is to enhance the adoption and utility of the human pangenome reference, which integrates diverse human genomes into a more representative resource. Key details include a funding budget up to $400,000 with a project duration of one year. Applications must focus on developing tools that facilitate the use of the pangenome, avoiding duplication of existing infrastructures. The NOFO emphasizes the need for innovative approaches that address significant gaps in genomic research and promote collaboration within the genomics community. Eligible applicants must be U.S.-based small businesses that meet specific criteria and demonstrate a commitment to ethical considerations in their research. The application process involves submission through Grants.gov, highlighting the importance of adhering to detailed guidelines to ensure compliance for review.
    Similar Opportunities
    Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Business Informatics Tools for the Pangenome," aimed at supporting small business concerns (SBCs) in developing innovative informatics tools that enhance the use of the human pangenome reference. This initiative specifically seeks Phase I Small Business Technology Transfer (STTR) applications that demonstrate the technical merit and commercial viability of these tools, targeting various sectors within genomics, including clinical and functional genomics. The program is designed to foster small business participation in genomics technology development, ultimately improving health outcomes through advanced genomic capabilities and data analysis tools. Eligible applicants can request funding up to $400,000 over a one-year period, with key deadlines for letter of intent and application submissions set for early 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)" aimed at developing informatics tools to enhance the use of the human pangenome reference. This initiative seeks applications that focus on creating tools relevant to various sectors of the genomics community, including clinical and population genomics, with the goal of improving accessibility and addressing genetic diversity to mitigate health disparities. Eligible applicants include a wide range of institutions, both domestic and foreign, with a maximum funding amount of $400,000 per year over three years, totaling up to $3 million for the program. Interested parties can find more information and submit inquiries via email to grantsinfo@nih.gov, with proposals due by March 3, 2025.
    Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)" aimed at developing informatics tools that enhance the use of a human pangenome reference as part of the Human Genome Reference Program (HGRP). The initiative seeks to fund projects that create broadly applicable tools for various sectors of genomics, including clinical and functional genomics, with a focus on improving analytical capabilities over existing methods. Up to $4 million will be allocated to support approximately six projects over a maximum period of three years, with individual project budgets capped at $400,000 annually. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for March 3, 2025.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that enhance understanding of genomic data applications, assess implementation methods, and identify barriers to health equity, particularly for underrepresented groups. The R03 grant mechanism supports small research projects with a maximum budget of $50,000 per year, with an estimated total funding of approximately $150,000 for two awards in fiscal year 2024. Applications must be submitted electronically by February 12, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovation in the application of genomic information in clinical care, particularly for populations experiencing health disparities. The initiative seeks to enhance understanding of how to effectively implement and share genomic technologies across diverse communities, including racial and ethnic minorities, underserved rural populations, and sexual and gender minority groups. With an expected total funding of approximately $1.5 million for fiscal year 2024, individual project budgets may reach up to $250,000. Interested applicants must submit their proposals by February 11, 2025, and can find additional details and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Genomic Community Resources (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-124) aimed at supporting the development of genomic community resources through cooperative agreements. This initiative seeks to enhance genomic research by funding projects that demonstrate broad applicability and significant value, focusing on the creation of genomic informatics tools, biological material collections, and community engagement efforts. The funded projects will play a crucial role in advancing both basic and clinical genomics research, with awards potentially lasting up to five years. Interested applicants, including a diverse range of organizations such as higher education institutions and nonprofits, must submit their applications by January 25, 2026, and can find further details and submission guidelines at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" aimed at advancing research in computational genomics, bioinformatics, and data visualization methodologies that enhance genomic science and its application to human health. This initiative seeks innovative projects that develop novel analytical tools and methodologies, with a budget limit of $275,000 for a two-year project period, focusing on scalable solutions applicable across various diseases and biological systems. The funding is particularly targeted at underrepresented entities in genomic research, including higher education institutions, nonprofits, and governmental bodies, reflecting NIH's commitment to fostering collaborative research in this critical field. Interested applicants should note that key submission dates begin on January 16, 2025, with a final expiration date of September 8, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.